Related references
Note: Only part of the references are listed.The neurobiological underpinning of the circadian wake signal
Jamie M. Zeitzer
BIOCHEMICAL PHARMACOLOGY (2021)
Animal models of narcolepsy and the hypocretin/orexin system: Past, present, and future
Ryan K. Tisdale et al.
SLEEP (2021)
Induction of narcolepsy-like symptoms by orexin receptor antagonists in mice
Mahesh K. Kaushik et al.
SLEEP (2021)
Structures of active-state orexin receptor 2 rationalize peptide and small-molecule agonist recognition and receptor activation
Chuan Hong et al.
NATURE COMMUNICATIONS (2021)
The hypocretin (orexin) system: from a neural circuitry perspective
Shi-Bin Li et al.
NEUROPHARMACOLOGY (2020)
Living with Narcolepsy: Current Management Strategies, Future Prospects, and Overlooked Real-Life Concerns
Emily C. Barker et al.
NATURE AND SCIENCE OF SLEEP (2020)
From orexin receptor agonist YNT-185 to novel antagonists with drug-like properties for the treatment of insomnia
Eva Mezeiova et al.
BIOORGANIC CHEMISTRY (2020)
Application of zebrafish to safety evaluation in drug discovery
Izuru Miyawaki
JOURNAL OF TOXICOLOGIC PATHOLOGY (2020)
Neural signatures of sleep in zebrafish
Louis C. Leung et al.
NATURE (2019)
Narcolepsy - clinical spectrum, aetiopathophysiology, diagnosis and treatment
Claudio L. A. Bassetti et al.
NATURE REVIEWS NEUROLOGY (2019)
Zebrafish-Based Discovery of Antiseizure Compounds from the North Sea: Isoquinoline Alkaloids TMC-120A and TMC-120B
Danielle Copmans et al.
MARINE DRUGS (2019)
Diurnal Regulation of the Orexin/Hypocretin System in Mice
Kathrin Ventzke et al.
NEUROSCIENCE (2019)
The neurobiological basis of narcolepsy
Carrie E. Mahoney et al.
NATURE REVIEWS NEUROSCIENCE (2019)
TAK-925, an orexin 2 receptor-selective agonist, shows robust wake-promoting effects in mice
Hiroshi Yukitake et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2019)
Recent advances in treatment for narcolepsy
Lucie Barateau et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2019)
Methylated flavonoids as anti-seizure agents: Naringenin 4 ',7-dimethyl ether attenuates epileptic seizures in zebrafish and mouse models
Danielle Copmans et al.
NEUROCHEMISTRY INTERNATIONAL (2018)
Epidemiology and Pathophysiology of Childhood Narcolepsy
Thomas J. Dye et al.
PAEDIATRIC RESPIRATORY REVIEWS (2018)
Daily Fluctuation of Orexin Neuron Activity and Wiring: The Challenge of Chronoconnectivity
Idris A. Azeez et al.
FRONTIERS IN PHARMACOLOGY (2018)
The roles of orexins in sleep/wake regulation
Michihiro Mieda
NEUROSCIENCE RESEARCH (2017)
Nonpeptide orexin type-2 receptor agonist ameliorates narcolepsy-cataplexy symptoms in mouse models
Yoko Irukayama-Tomobe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Modeling sleep and neuropsychiatric disorders in zebrafish
Talia Levitas-Djerbi et al.
CURRENT OPINION IN NEUROBIOLOGY (2017)
Generic GPCR residue numbers - aligning topology maps while minding the gaps
Vignir Isberg et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
Pharmacological profiling of zebrafish behavior using chemical and genetic classification of sleep-wake modifiers
Yuhei Nishimura et al.
FRONTIERS IN PHARMACOLOGY (2015)
Discovering novel neuroactive drugs through high-throughput behavior-based chemical screening in the zebrafish
Giancarlo Bruni et al.
FRONTIERS IN PHARMACOLOGY (2014)
Circadian clocks, rhythmic synaptic plasticity and the sleep-wake cycle in zebrafish
Idan Elbaz et al.
FRONTIERS IN NEURAL CIRCUITS (2013)
Discovery of the Dual Orexin Receptor Antagonist [(7R)-4-(5-Chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone (MK-4305) for the Treatment of Insomnia
Christopher D. Cox et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Hypocretin/orexin overexpression induces an insomnia-like phenotype in zebrafish
David A. Prober et al.
JOURNAL OF NEUROSCIENCE (2006)
Hypocretin (orexin) deficiency in human narcolepsy
S Nishino et al.
LANCET (2000)
Share Paper
